RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025)
RedHill Biopharma's (RDHL) quarterly Enterprise Value came in at -$4.0 million in Q4 2025, up 34.23% year-on-year from -$3.0 million in Q4 2024, and up 14.2% on a QoQ basis from -$4.6 million in Q2 2025.
RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has 15 years of Enterprise Value data on file, last reported at -$4.0 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 34.23% year-over-year to -$4.0 million in Q4 2025; TTM through Dec 2025 was -$4.0 million, a 34.23% increase from a year earlier, with the FY2025 full-year figure at -$4.6 million, up 33.95% from the prior year.
- Enterprise Value for Q4 2025 stood at -$4.0 million, up from -$4.6 million in the prior quarter.
- Over the last five years, Enterprise Value for RDHL reached as high as -$4.0 million in Q4 2025 and fell as low as -$76.4 million in Q1 2021.
- Historically, Enterprise Value has averaged -$28.4 million across 5 years, with a median of -$22.6 million in 2022.
- Across the five-year window, Enterprise Value sank 49.2% in 2021 and surged 72.07% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$29.9 million in 2021, then advanced by 24.57% to -$22.6 million in 2022, then jumped by 72.07% to -$6.3 million in 2023, then grew by 4.31% to -$6.0 million in 2024, then jumped by 34.23% to -$4.0 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$4.0 million in Q4 2025, -$4.6 million in Q2 2025, and -$6.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -3.97 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -153.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.97 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -6.04 Mn |
| Jun 30, 2024 | -9.82 Mn |
| Dec 31, 2023 | -6.31 Mn |
| Jun 30, 2023 | -21.60 Mn |
| Mar 31, 2023 | -19.20 Mn |
| Dec 31, 2022 | -22.59 Mn |
| Sep 30, 2022 | -32.41 Mn |
| Jun 30, 2022 | -35.55 Mn |
| Mar 31, 2022 | -29.47 Mn |
| Dec 31, 2021 | -29.95 Mn |
| Sep 30, 2021 | -52.29 Mn |
| Jun 30, 2021 | -76.45 Mn |
| Mar 31, 2021 | -76.45 Mn |
| Dec 31, 2020 | -37.22 Mn |
| Sep 30, 2020 | -35.05 Mn |
| Jun 30, 2020 | -86.13 Mn |
| Mar 31, 2020 | -87.81 Mn |
| Dec 31, 2019 | -40.78 Mn |